Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Thromb Haemost. 2013 May;11(5):911–918. doi: 10.1111/jth.12188

Fig. 2.

Fig. 2

TFPIβ is an effective inhibitor TF-FVIIa and FXa. (A) TF-FVIIa-mediated FXa generation (mean ± SEM, n=3) and (B) FXa activity (mean ± SEM, n=3) were measured in the presence of glycosylated TFPIα (□), non-glycosylated TFPIα (■), TFPI-160 (▲) or CHO-TF/TFPIβ cells (●). Cellular TF was constant in all experiments. Data are shown as percent activity compared to the “no TFPI” control in (A) or as uninhibited FXa activity in (B).